The information era we’re in drives us to make a variety of choices based on the data we have access to. In this sense, quality data management needs to be handled by companies investing in a digital presence and strategy. Without a doubt, data management in the pharmaceutical industry will have a relevant role.
Even outside of this context, this information remains a driving force on the path to better outcomes for a company. In fact, life sciences need to focus on good data management, and we’re about to show you why.
Why is data management vital in the “new normal”?
It’s undeniable that the data that we have available right now can be overwhelming to the people who analyze it. Every day, millions upon millions of data elements are being produced. This is one of the main reasons why companies in several sectors need to invest in educating their task forces on data management.
Today, the number of job positions requiring the use of a computer is growing. This is putting companies and professionals in contact with millions of sources of information every day. The issue of poor data quality can cost millions to several companies per year. Many financial and operational performances can suffer tremendous consequences due to this issue.
Many IT companies have developed tools that can help in the management and processing of data. For pharmaceutical companies, this will be a significant advancement in gaining a better strategic advancement in the “new normal” era.
Data management in pharma will rule over many decisions
Alike other sectors, pharma nowadays has to work with a wide variety of data. This element comes from internal and external sources.
Each data source has a format and structure. This is why the proper tools to dissect this information are vital. In this sense, a holistic data managing approach helps drive strong partnerships. It also contributes to seamless cooperation.
The type of data available to pharma companies will determine many of their strategic decisions. Healthcare, in particular, is noticing a huge amount of data reaching them both from internal operations and from valuable partners and stakeholders.
Thanks to the digital disruption in this sector, there are new sources of data coming to several healthcare sectors. Take wearables as an example of a new source of information. These elements come as a result of the role that these gadgets have started to play in recent years. Nowadays, these elements allow many organizations to collect valuable information on the health of their users.
Pharma and data management
Pharma companies are one of the main sectors trying to extend the impact of their marketing campaigns. The people working in this area are using new technologies to discover the advantages of new engagement channels. Overall, pharmaceutical companies are using these elements to establish new forms of contact based on the data that comes to them.
This sector needs to take advantage of these new communication channels. After all, proper data management in pharma will allow them to engage with stakeholders, physicians, and patients.
Here, data leveraging and other insights will have a vital part to play. A robust data pipeline will be the main key to a successful data operation.
For pharma, the data platforms at play here must be agile. At the same time, they need to play several roles, from analyzing and processing data in various formats to generating insights from several data feeds. Due to this, the business and tech teams in pharma are under immense pressure.
When designing a data management system for data management and processes, there are numerous factors to consider. To enable data to provide faster results, there are three main elements to consider when interpreting data:
- Faultless integration with several technologies and sources for data;
- Agility in providing data, regardless of its source, size, and features;
- Simplification of relevant data, considering essential KPIs (key performance indicators).
In this sense, a centralized data strategy will guide several companies to better business outcomes when it comes to data management in pharma. Cloud-based data platforms are the biggest facilitators in the building of global systems. At the same time, they are enabling remote modules to drive data compliance.
The concept of “big data”
The term “big data” refers to massive and varied databases. These are generated by the recording of several digital touchpoints everywhere. This type of data can come from a variety of sources, such as:
- Website analytics
- Customer feedback
- Social media activity
- E-mail activity
- Paid campaign results online
- And more
This data is often collected through algorithms that track web users based on specific patterns. In fact, big data comes into this picture as a way to simplify several data management processes.
An interesting detail about these analytics tools is that many of them are embedded in cloud-based infrastructures. Generally speaking, this makes it easier for pharma companies to build new robust systems to meet their needs.
What to consider before implementing big data analytics
Big data analytics is an element that provides pharma organizations with opportunities to stop relying on manual entries of information. This can also help these companies learn about complex details related to drug safety, clinical studies, and inventory control.
Of course, there are considerable challenges to consider before deciding on implementing big data in pharma companies. Some of them involve factors such as:
- Costs related to the implementation;
- Costs of big data storage;
- Lack of workers with solid experience in handling data;
- The effort to interpret several pharma datasets;
- Fear of innovation, more specifically of tackling unknown tools.
Yet, for this action to be successfully implemented, a pharmaceutical company needs to ponder its needs in this spectrum. In fact, there are a variety of solution providers or strategic partners with experience to help companies set up a proper system to help them interpret data.
Data interpretation will dictate the future of many companies. Through a well-elaborated strategy, pharmaceutical organizations will have a better insight into the internal and external factors surrounding their company.
Not only will it have a positive impact on marketing decisions, but it will also help in the optimization and organization of many relevant data details surrounding an organization.
Artificial intelligence (AI) tools will evolve into a myriad of possibilities in a couple of years. As more and more organizations start to test these possibilities, this growth will become a reality. However, there are several steps that must be taken before this is possible.
Pharmaceutical companies need to reflect on processes such as:
- Defining goals
- Opting for solutions partners
- Reviewing undergoing processes
- Refining use cases
- Comprehending technological capabilities.
There’s unlimited potential for new elements within this undergoing evolution. In the long run, pharma companies can explore these possibilities to modernize their communication online.
There is a new way to convert data into video. RedNovius has an idea to turn your amazing medical data into an engaging experience.
Our services, PubVisual and PatientVisual, will allow your scientific reports to be turned into engaging video content. It’s fit for either HCPs or patients. Book your meeting and discover how we can help!